✦ LIBER ✦

P387 Persistence of antibodies to infliximab for more than two months strongly predicts loss of response to infliximab in inflammatory bowel diseases

✍ Scribed by Leclerc, M.; Marotte, H.; Paul, S.; Del Tedesco, E.; Gonzalo, P.; Phelip, J.M.; Peyrin Biroulet, L.; Roblin, X.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sa1257 Persistence of Antibodies to Infl

✍ Leclerc, Manon; Marotte, Hubert; Paul, Stephane; Del Tedesco, Emilie; Phelip, Je 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 231 KB

Trough levels and antibodies to inflixim

✍ Benjamin Pariente; Guillaume Pineton de Chambrun; Roman Krzysiek; Marine Desroch 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 320 KB

P.06.20 ROLE OF TROUGH LEVELS AND ANTIBO

✍ Marzo, M.; Armuzzi, A.; Felice, C.; Pugliese, D.; Andrisani, G.; Tolusso, B.; Gr 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 851 KB

P508 Evaluation of the diagnostic perfor

✍ Daperno, M.; Frigerio, F.; Guiotto, C.; Germano, L.; Ercole, E.; Aricò, S.; Frac 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 143 KB

P.03.13 COMPARISON OF THE PERFORMANCE OF

✍ Daperno, M.; Frigerio, F.; Guiotto, C.; Laura, G.; Ercole, E.; Lavagna, A.; Riga 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Tu1168 Identical Diagnostic Performance

✍ Daperno, Marco; Frigerio, Francesco; Guiotto, Cristina; Germano, Laura; Ercole, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 123 KB